| | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2023 ( Subtotal = $860,262 ) |
| 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cardiovascular Diseases Research | 000 | 4 | 8/9/2023 | NON-COMPETING CONTINUATION | $860,262 |
|
 | Issue Date FY: 2022 ( Subtotal = $862,762 ) |
| 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cardiovascular Diseases Research | 000 | 3 | 7/14/2022 | NON-COMPETING CONTINUATION | $862,762 |
|
 | Issue Date FY: 2021 ( Subtotal = $864,762 ) |
| 2021 | 2021 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cardiovascular Diseases Research | 000 | 2 | 7/28/2021 | NON-COMPETING CONTINUATION | $864,762 |
|
 | Issue Date FY: 2020 ( Subtotal = $946,194 ) |
| 2020 | 2020 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Cardiovascular Diseases Research | 000 | 1 | 6/10/2020 | NEW | $946,194 |
|
|